Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.63 |
| ▸ | CA9 | Q16790 | 6/20 | 0.63 |
| ▸ | CA1 | P00915 | 5/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | AR | P10275 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27447210 | 1.00 | CA2 (0.63) | CA2CA9CA1TSHRAR | |
| Formaldehyde SCHEMBL28740532 | 0.96 | CA2 (0.59) | CA2CA9CA1TSHRAR | |
| Ethyne SCHEMBL28196610 | 0.96 | CA2 (0.59) | CA2CA9CA1TSHRAR | |
| SCHEMBL27571883 | 0.94 | TSHR (0.60) | CA2CA9CA1TSHRAR | |
| SCHEMBL9502200 | 0.92 | CA2 (0.55) | CA2CA9CA1TSHRAR | |
| SCHEMBL4952656 | 0.88 | CA2 (0.58) | CA2CA9CA1TSHRAR | |
| SCHEMBL6286312 | 0.88 | IDO1 (0.52) | CA2CA9CA1TSHRIDO1 | |
| SCHEMBL874437 | 0.87 | AR (0.62) | CA2CA9CA1ARNPC1 | |
| SCHEMBL29264749 | 0.87 | ALDH1A1 (0.50) | CA2CA9CA1TSHRAR | |
| SCHEMBL633239 | 0.86 | CA2 (0.53) | CA2CA9CA1TSHRAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 673 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025254-A | Preparation method of epothilone hydrochloride intermediate | 甘肃皓天医药科技有限责任公司 | 2025-05-23 | — | — | CN | claimed |
| CN-117241773-A | Polymer medicine bottle with standard external dimensions and reduced internal volume | SIO2医疗产品有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-107056733-B | 3-O-(with anticancer activity is to methanesulfonates benzyl) ascorbic acid and preparation method | 中国药科大学 | 2019-09-03 | — | — | CN | claimed |
| CN-109369619-A | Phthalazines ketone compound crystal form B and preparation method thereof | 南京先进生物材料与过程装备研究院有限公司 | 2019-02-22 | — | — | CN | claimed |
| CN-109336864-A | Phthalazines ketone compound crystal form N and preparation method thereof | 南京先进生物材料与过程装备研究院有限公司 | 2019-02-15 | — | — | CN | claimed |
| CN-109288830-A | A kind of taxol and novel phthalazines ketone compounds drug combination compositions | 南京先进生物材料与过程装备研究院有限公司 | 2019-02-01 | — | — | CN | claimed |
| CN-109180644-A | A kind of mesylate of novel B TK kinase inhibitor and preparation method thereof and purposes | 南京先进生物材料与过程装备研究院有限公司 | 2019-01-11 | — | — | CN | claimed |
| CN-109180643-A | Phthalazines ketone compound crystal form A and preparation method thereof | 南京先进生物材料与过程装备研究院有限公司 | 2019-01-11 | — | — | CN | claimed |
| CN-109172592-A | A kind of antineoplastic pharmaceutical compositions | 南京先进生物材料与过程装备研究院有限公司 | 2019-01-11 | — | — | CN | claimed |
| CN-108218800-A | 1,2,3- triazole aminopeptidase N inhibitor and its preparation method and application | 山东大学 | 2018-06-29 | — | — | CN | claimed |
| CN-1662522-A | Novel compounds, their use and preparation | BIOVITRUM AB (SE) | 2005-08-31 | — | — | CN | claimed |
| WO-2005076749-A2 | A NOVEL PROCESS FOR THE PREPARATION OF 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE | JUBILANT ORGANOSYS LIMITED (IN) | 2005-08-25 | — | — | WO | claimed |
| EP-1513831-A1 | NOVEL COMPOUNDS, THEIR USE AND PREPARATION | Biovitrum AB (SE) | 2005-03-16 | — | — | EP | claimed |
| US-20040029888-A1 | Novel compounds, their use and preparation | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2004-02-12 | — | — | US | claimed |
| WO-2004000830-A1 | NOVEL COMPOUNDS, THEIR USE AND PREPARATION | BIOVITRUM AB (SE) | 2003-12-31 | — | — | WO | claimed |
| EP-0802904-B1 | SUBSTITUTED 2-PHENYLPYRIDINES AS HERBICIDES | BASF AG (DE) | 1998-09-09 | — | — | EP | claimed |
| CN-1172477-A | Substituted 2 -phenylpyridines as herbicides | BASF AG (DE) | 1998-02-04 | — | — | CN | claimed |
| EP-0079134-B1 | STEREOSPECIFIC SYNTHESIS OF 5-PHENYL-2S-PENTANOL | PFIZER INC. (US) | 1985-02-06 | — | — | EP | claimed |
| US-4412958-A | Stereospecific synthesis of 5-phenyl-2S-pentanol | PFIZER INC. (US) | 1983-11-01 | — | — | US | claimed |
| EP-0079134-A1 | Stereospecific synthesis of 5-phenyl-2S-pentanol | PFIZER INC. (US) | 1983-05-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029888-A1 | Novel compounds, their use and preparation | TPH1, TPH2, HTR1A | CA2 4669/4885CA9 4529/4885CA1 2572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.